An annual day of health advocacy focused on the diagnosis and treatment of a rare form of psoriasis. ALEXANDRIA, VA, ...

Dermatology drugmaker Leo Pharma and the scattering of patients across the globe with rare skin disease generalized pustular psoriasis (GPP) are circling Aug. 13 on their calendars as the second ...

Detailed price information for Oruka Therapeutics Inc (ORKA-Q) from The Globe and Mail including charting and trades.

Phase 3 IZAR-1 trial in bio-naïve patients met all clinical endpoints at Week 16 for 60 mg sonelokimabThe primary endpoint of ACR50 was met with ...

ZUG, Switzerland, June 21, 2026 - MoonLake Immunotherapeutics (NASDAQ: MLTX) (MoonLake or the Company), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory ...

Pustular psoriasis of pregnancy (PPP) is a rare dermatosis of pregnancy that can lead to life-threatening maternal and fetal complications. Risk of recurrence in subsequent pregnancies is high, with ...

Clinicians should recognize Th2 blockade-driven immune shifts as a potential mechanism and monitor for psoriasiform eruptions during therapy. Dupilumab therapy for bullous pemphigoid (BP) may ...

Evidence in cases with GPP remains limited but suggests a rapid and marked clinical benefit within weeks. Janus kinase inhibitors (JAKi) demonstrated high response rates and rapid clinical improvement ...

A retrospective US claims study found that adults with generalized pustular psoriasis (GPP) had significantly more healthcare visits and costs than patients with plaque psoriasis alone. Researchers ...

IN a compelling case that underscores the complexity of biologic therapies, a patient with hidradenitis suppurativa (HS) developed adalimumab-induced pustular psoriasis, which was successfully treated ...

Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents are frequently observed, according to a study recently published online in ...